Alerts will be sent to your verified email
Verify Email
SANJIVIN
|
Sanjivani Paranteral
|
Natural Capsules
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Quarterly Sales Volume - Injectables
|
n/a | n/a | n/a |
|
Quarterly Sales Volume - Orals
|
n/a | n/a | n/a |
|
Quarterly Sales Volume - Nutraceuticals
|
n/a | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-37.68 % | 9.1 % | 10.1 % |
|
5yr average Equity Multiplier
|
-1.69 | 1.91 | -1.22 |
|
5yr Average Asset Turnover Ratio
|
1.39 | 0.61 | 1.1 |
|
5yr Avg Net Profit Margin
|
7.02 % | 6.68 % | -16.74 % |
|
Price to Book
|
7.11 | 1.21 | 0.0 |
|
P/E
|
33.28 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-55.03 Days | 25.72 Days | -56.32 Days |
|
Inventory Days
|
28.68 Days | 27.47 Days | 94.46 Days |
|
Days Receivable
|
21.4 Days | 125.88 Days | 80.66 Days |
|
Days Payable
|
284.6 Days | 118.63 Days | 174.19 Days |
|
5yr Average Interest Coverage Ratio
|
15.99 | 7.96 | -3.11 |
|
5yr Avg ROCE
|
-87.74 % | 10.02 % | -80.86 % |
|
5yr Avg Operating Profit Margin
|
9.71 % | 14.83 % | -18.99 % |
|
5 yr average Debt to Equity
|
-0.72 | 0.51 | -1.55 |
|
5yr CAGR Net Profit
|
n/a | -38.15 % | -9.68 % |
|
5yr Average Return on Assets
|
11.72 % | 4.68 % | -10.42 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
28.87 % | 51.26 % | 57.95 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.52 % | -5.31 % | 45.62 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.04 % |
|
Sanjivani Paranteral
|
Natural Capsules
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|